Andrew A. Krakauer, CEO at CANTEL MEDICAL CORP (CMN), sold 9,438 shares at $62.49 ($590K) on 2015-12-28, disclosed to the SEC on 2015-12-31.
Seasonal sale ($590k) by CEO — this insider has traded CMN in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TFX | BUY | 2018-08-08 | $238K | — | Filing → |
| CMN | SELL | 2015-10-14 | $1.2M | — | Filing → |
| CMN | SELL | 2014-12-29 | $815K | — | Filing → |